Thomas Andrew Davis Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Thomas Andrew Davis.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Thomas Andrew Davis. Thomas Andrew Davis is Executive VP & CMO in Celldex Therapeutics, Inc. ($AVAN) and Chief Medical Officer in GENVEC INC ($GNVC) and CHIEF MEDICAL OFFICER in GENOCEA BIOSCIENCES, INC. ($GNCA).
Latest Insider Trading Transactions of Thomas Andrew Davis
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CLDX, GNCA, GNVC
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Davis Thomas Andrew | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
| Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Davis Thomas Andrew | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
| Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Davis Thomas Andrew | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 3.01 | 93,750 | 282,188 | 93,750 | |
| Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Davis Thomas Andrew | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 3.01 | 93,750 | 282,188 | 93,750 | |
| Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Davis Thomas Andrew | CHIEF MEDICAL OFFIC ... | Grant | A | 0.00 | 31,250 | 0 | 31,250 | 0 to 31.3 K |
| Mar 17 2021 | GNCA | GENOCEA BIOSCIENCE ... | Davis Thomas Andrew | CHIEF MEDICAL OFFIC ... | Grant | A | 0.00 | 31,250 | 0 | 31,250 | 0 to 31.3 K |
| Jun 02 2020 | GNCA | GENOCEA BIOSCIENCE ... | Davis Thomas Andrew | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 2.72 | 24,938 | 67,831 | 24,938 | |
| Jun 02 2020 | GNCA | GENOCEA BIOSCIENCE ... | Davis Thomas Andrew | CHIEF MEDICAL OFFIC ... | Grant | A | 0.00 | 6,623 | 0 | 6,623 | 0 to 6.6 K |
| Apr 06 2020 | GNCA | GENOCEA BIOSCIENCE ... | Davis Thomas Andrew | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 1.66 | 46,313 | 76,880 | 46,313 | |
| Apr 06 2020 | GNCA | GENOCEA BIOSCIENCE ... | Davis Thomas Andrew | CHIEF MEDICAL OFFIC ... | Grant | A | 0.00 | 12,299 | 0 | 12,299 | 0 to 12.3 K |
| Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Davis Thomas Andrew | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 0.54 | 300,000 | 162,000 | 300,000 | |
| Feb 11 2019 | GNCA | GENOCEA BIOSCIENCE ... | Davis Thomas Andrew | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 0.54 | 300,000 | 162,000 | 300,000 | |
| Oct 02 2018 | GNCA | GENOCEA BIOSCIENCE ... | Davis Thomas Andrew | CHIEF MEDICAL OFFIC ... | Option Exercise | A | 0.79 | 500,000 | 395,000 | 500,000 | |
| Jun 16 2017 | AVAN | Celldex Therapeuti ... | Davis Thomas Andrew | Executive VP & CMO | Option Exercise | A | 2.32 | 150,000 | 348,000 | 150,000 | |
| Jun 09 2016 | AVAN | Celldex Therapeuti ... | Davis Thomas Andrew | Executive VP & CMO | Option Exercise | A | 4.72 | 157,000 | 741,040 | 157,000 | |
| Jun 11 2015 | AVAN | Celldex Therapeuti ... | Davis Thomas Andrew | Executive VP & CMO | Option Exercise | A | 25.41 | 116,500 | 2,960,265 | 116,500 | |
| Jan 26 2006 | GNVC | GENVEC INC | Davis Thomas Andrew | Chief Medical Offic ... | Option Exercise | A | 1.69 | 50,000 | 84,500 | 50,000 | |
| Jan 05 2006 | GNVC | GENVEC INC | Davis Thomas Andrew | Chief Medical Offic ... | Buy | P | 1.82 | 5,000 | 9,100 | 5,000 | 0 to 5 K |
Page: 1